{"entity":{"id":"nct02584244","kind":"trial","name":"Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers","aka":[],"tldr":"A phase 1/2 trial of LUM015 in colorectal cancer, pancreatic ductal adenocarcinoma, oesophageal cancer and gastric & gastro-oesophageal junction cancer, run by Lumicell, Inc., now recruiting.","summary":"Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers is a phase 1/2 interventional study registered as NCT02584244 by Lumicell, Inc., with 66 participants planned, started 2016-08-04 and due to reach its primary completion in 2026-12. Interventions recorded: LUM015 and LUM 2.6 Imaging Device.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT02584244","url":"https://clinicaltrials.gov/study/NCT02584244"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["colorectal","pancreatic","esophageal","gastric"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["lumicell"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT02584244","phase":"1/2","setting":"Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers","sponsor":"Lumicell, Inc.","enrolled":66,"outcomes":[]},"route":"/trials/nct02584244/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"esophageal","kind":"cancer","name":"Oesophageal cancer","route":"/cancers/esophageal/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"company":[{"id":"lumicell","kind":"company","name":"Lumicell","route":"/companies/lumicell/"}]}}